Actively Recruiting
This Clinical Investigation Assesses the Safety and Performance of a New Beamformer for MED-EL Cochlear Implant Recipients.
Led by MED-EL Elektromedizinische Geräte GesmbH · Updated on 2026-04-23
40
Participants Needed
2
Research Sites
39 weeks
Total Duration
On this page
Sponsors
M
MED-EL Elektromedizinische Geräte GesmbH
Lead Sponsor
M
Medizinische Universität Innsbruck, Universitätsklinik für Hör-, Stimm-, und Sprachstörungen
Collaborating Sponsor
AI-Summary
What this Trial Is About
Cochlear implants help individuals with hearing loss by delivering electrical signals directly to the auditory nerve, bypassing damaged parts of the ear. While they significantly improve speech perception in quiet environments and over the telephone, challenges remain in noisy environments due to interference from background noise. To address this, advancements in signal-processing strategies, microphone technology, and noise-reduction algorithms have been introduced. The focus of the study is on two new front-end features: * Focused Beamformer - Enhances directional hearing. * AI Mode Medium - Utilizes the adaptive intelligence for optimized sound processing.
CONDITIONS
Official Title
This Clinical Investigation Assesses the Safety and Performance of a New Beamformer for MED-EL Cochlear Implant Recipients.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Minimum age of eighteen (18) years at time of enrolment
- Experienced MED-EL cochlear implant (CI) user (≥ 6 months) for the ear to be tested
- User of a MED-EL Audio Processor (i.e. a SONNET, SONNET 2, SONNET 3, or RONDO 3 ≥ 3 months)
- Post-lingual onset of severe to profound sensory-neural hearing loss on the ear to be tested
- A minimum of 40% speech recognition in the Freiburg Monosyllables Test in quiet at 65 dB sound pressure level (SPL) for the ear to be tested (at the last time tested in clinical routine)
- Signed and dated Informed Consent Form (ICF) before the start of any study-specific procedure.
You will not qualify if you...
- Lack of compliance with any inclusion criteria
- CI user with contralateral hearing equal to or better than 30 dB (pure-tone average over the following frequencies: 250, 500, 1000, and 2000 Hz)
- Implanted with C40X, or C40C on the ear to be tested
- Implanted with an auditory brainstem implant (ABI) or Split electrode array
- Known allergic reactions to components of the investigational medical device
- Anything that, in the opinion of the Investigator, would place the subject at increased risk or preclude the subject's full compliance with or completion of the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Medizinische Universität Innsbruck, Universitätsklinik für Hör-, Stimm-, und Sprachstörungen
Innsbruck, Austria
Actively Recruiting
2
Universitätsklinikum St. Pölten, Abteilung für Hals-, Nasen- und Ohrenerkrankungen
Sankt Pölten, Austria
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here